| Dr Diane Dawn Heasley, DO | |
|
6116 E Warren Ave, Denver, CO 80222-5703 | |
| (303) 512-0888 | |
| (303) 512-2288 |
| Full Name | Dr Diane Dawn Heasley |
|---|---|
| Gender | Female |
| Speciality | Pathology - Anatomic Pathology & Clinical Pathology |
| Location | 6116 E Warren Ave, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073582672 | NPI | - | NPPES |
| 641789 | Medicaid | AZ | |
| Z7622 | Medicaid | NM | |
| 01355205 | Medicaid | CO | |
| Z0237 | Medicaid | UT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZD0900X | Pathology - Dermatopathology | 35520 (Colorado) | Secondary |
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | 35520 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Diane Dawn Heasley, DO 103 Continental Pl, Ste 400, Brentwood, TN 37027-1073 Ph: (615) 916-3200 | Dr Diane Dawn Heasley, DO 6116 E Warren Ave, Denver, CO 80222-5703 Ph: (303) 512-0888 |
News Archive
The top executive of Wellpoint, a major health insurer, called for health reform at a meeting of the Economic Club in Indianapolis Tuesday, WTHR, the local NBC affiliate, reports. "The high and rising cost of health care in America is just not sustainable …" said CEO Angela Braly. Those costs pose "a real threat to the social and fiscal obligations of the government and to the health and prosperity of the American people."
While studying the mechanics of blood clots, researchers at the University of Oklahoma Health Sciences Center discovered a new enzyme that not only affects the blood, but seems to play a primary role in how cancer tumors expand and spread throughout the body.
Hepatitis C virus (HCV) infection affects about 4 million in the United States and is the primary cause of liver cirrhosis and liver cancer. Current therapy against HCV is suboptimal. Daclatasvir, a direct acting antiviral (DAA) agent in development for the treatment of HCV, targets one of the HCV proteins (i.e., NS5A) and causes the fastest viral decline (within 12 hours of treatment) ever seen with anti-HCV drugs.
Human white blood cells, engineered to recognize other malignant immune cells, could provide a novel therapy for patients with highly lethal B cell cancers such as acute lymphoblastic leukemia (ALL), according to researchers at Memorial Sloan-Kettering Cancer Center (MSKCC).
› Verified 5 days ago
Michael L Wilson, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 777 Bannock St, Mc 7782, Denver, CO 80204 Phone: 303-436-6000 | |
Shalini Chahal, MD Pathology Medicare: Medicare Enrolled Practice Location: 4567 E 9th Ave, Denver, CO 80220 Phone: 303-320-2250 Fax: 303-320-2361 | |
Dr. Scott Andrew Whitworth, M.D. Pathology Medicare: Medicare Enrolled Practice Location: 11000 E 45th Ave, Denver, CO 80239 Phone: 303-338-4545 | |
Terry L Andres, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 11000 E 45th Ave, Denver, CO 80239 Phone: 303-338-4545 | |
Dr. Thomas Alton Merrick, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6116 E Warren Ave, Denver, CO 80222 Phone: 303-512-0888 Fax: 303-512-2288 | |
Loretta B Gaido, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 777 Bannock St, Mc 7782, Denver, CO 80204 Phone: 303-436-6000 | |
Dr. Amy Elizabeth Schmidt, MD, PHD Pathology Medicare: Medicare Enrolled Practice Location: 1719 E 19th Ave, Denver, CO 80218 Phone: 720-754-6851 Fax: 303-869-1786 |